US · Healthcare · Biotechnology
EPS came in at -0.05 against a street estimate of -0.11 — a beat of 54.5%.
Analysts rate OmniAb Inc. a strong buy (7 buy, 0 hold, 0 sell out of 7) with an average price target of $8.33.
| Fund | Stake |
|---|---|
| Whitefort Capital Management, LP. | 7.05% |
| BlackRock Inc | 6.12% |
| Nomura Holdings Inc | 3.46% |
| Cadian Capital Management LP | 2.90% |
| Vanguard Capital Management, LLC | 2.65% |
| Geode Capital Management, LLC | 1.98% |
| Rice Hall James & Associates, LLC | 1.80% |
| Private Management Group Inc | 1.61% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 OMNIAB, INC. – FORM 10-Q SUMMARY (Q2 2026) HEADLINE NUMBERS • Total Revenue (6 months ended June 30, 2026): $27.8 million, up 246% vs. $8.1 million | 2026-08-06 |
| Results announced · Q3 2026 OMNIAB, INC. – Q2 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 Revenue: $13.4 million vs. $3.9 million in Q2 2025 (244% increase) - L | 2026-08-06 |
| Board / officer change · Q3 2026 OMNIAB, INC. - FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • New Chief Operating Officer appointed: Amechi Nwachuku appointed as COO effective Ju | 2026-07-13 |
| Shareholder vote results · Q2 2026 OMNIAB, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Annual shareholder meeting held June 17, 2026 • Company trades on Nasdaq Global Market under tick | 2026-06-18 |
| Quarterly report · Q1 2026 OMNIAB, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash and cash equivalents: $29,046 thousand (March 31, 2026) vs. $25,524 thousand (December 3 | 2026-05-07 |
| Results announced · Q2 2026 OMNIAB Q1 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Q1 2026 Revenue: $14.4 million vs. $4.2 million in Q1 2025 (243% increase), primarily fr | 2026-05-07 |
| Proxy statement · Q2 2026 OMNIAB, INC. 2026 PROXY STATEMENT SUMMARY CEO COMPENSATION • Matthew W. Foehr (President, CEO, Director) earned $2,189,750 in total compensation for | 2026-04-29 |
| Annual report FY2025 OMNIAB, INC. – 2025 ANNUAL REPORT SUMMARY HEADLINE NUMBERS • Market cap: ~$144.9 million (as of June 30, 2025) • Outstanding shares: 144,782,647 com | 2026-03-04 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for OmniAb Inc. — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.